Evidence map›Paper›PMID 37409321›Full record

ReviewDEN open2024

Alcohol consumption, multiple Lugol-voiding lesions, and field cancerization.

Chikatoshi Katada, Tetsuji Yokoyama, Tomonori Yano, Haruhisa Suzuki, Yasuaki Furue, Keiko Yamamoto, Hisashi Doyama, Tomoyuki Koike, Masashi Tamaoki, Noboru Kawata and 18 more

Open access · goldAbstract readReview
In one paragraph

Review in DEN open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 19 institutions in 1 country.

Chikatoshi KatadaDepartment of Therapeutic Oncology Graduate School of Medicine, Kyoto University Kyoto Japan.ORCID https://orcid.org/0000-0002-2713-4661
Tetsuji YokoyamaDepartment of Health and Promotion National Institute of Public Health Saitama Japan.
Tomonori YanoDepartment of Gastroenterology and Endoscopy National Cancer Center Hospital East Chiba Japan.
Haruhisa SuzukiEndoscopy Division National Cancer Center Hospital Tokyo Japan.
Yasuaki FurueDepartment of Gastroenterology Kitasato University School of Medicine Kanagawa Japan.
Keiko YamamotoDivision of Endoscopy Hokkaido University Hospital Hokkaido Japan.
Hisashi DoyamaDepartment of Gastroenterology Ishikawa Prefectural Central Hospital Ishikawa Japan.
Tomoyuki KoikeDivision of Gastroenterology Tohoku University Graduate School of Medicine Miyagi Japan.ORCID https://orcid.org/0000-0001-6472-3257
Masashi TamaokiDepartment of Therapeutic Oncology Graduate School of Medicine, Kyoto University Kyoto Japan.
Noboru KawataDivision of Endoscopy Shizuoka Cancer Center Shizuoka Japan.
Motohiro HiraoDepartment of Surgery National Hospital Organization Osaka National Hospital Osaka Japan.
Yoshiro KawaharaDepartment of Practical Gastrointestinal Endoscopy Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Okayama Japan.
Takashi OgataDepartment of Gastroenterology Kanagawa Cancer Center Kanagawa Japan.
Atsushi KatagiriDepartment of Medicine, Division of Gastroenterology Showa University Hospital Tokyo Japan.
Takenori YamanouchiDepartment of Gastroenterology Kumamoto Regional Medical Center Kumamoto Japan.
Hirofumi KiyokawaDivision of Gastroenterology, Department of Internal Medicine St. Marianna University School of Medicine Kanagawa Japan.
Hirofumi KawakuboDepartment of Surgery Kawasaki Municipal Kawasaki Hospital Kanagawa Japan.
Maki KonnoDepartment of Gastroenterology Tochigi Cancer Center Tochigi Japan.
Akira YokoyamaDepartment of Therapeutic Oncology Graduate School of Medicine, Kyoto University Kyoto Japan.
Shinya OhashiDepartment of Therapeutic Oncology Graduate School of Medicine, Kyoto University Kyoto Japan.
Yuki KondoDepartment of Therapeutic Oncology Graduate School of Medicine, Kyoto University Kyoto Japan.
Yo KishimotoDepartment of Otolaryngology-Head and Neck Surgery Kyoto University Hospital Kyoto Japan.
Koichi KanoDepartment of Otorhinolaryngology-Head and Neck Surgery Kitasato University School of Medicine Kanagawa Japan.
Kanae MureDepartment of Public Health Wakayama Medical University School of Medicine Wakayama Japan.
Ryuichi HayashiDepartment of Head and Neck Surgery National Cancer Center Hospital East Chiba Japan.
Hideki IshikawaDepartment of Molecular-Targeting Prevention Kyoto Prefectural University of Medicine Kyoto Japan.
Akira YokoyamaClinical Research Unit National Hospital Organization Kurihama Medical and Addiction Center Kanagawa Japan.
Manabu MutoDepartment of Therapeutic Oncology Graduate School of Medicine, Kyoto University Kyoto Japan.
Kyoto University · JPNational Cancer Center Hospital East · JPKitasato University · JPHokkaido University Hospital · JPIshikawa Prefectural Central Hospital · JPKanagawa Prefectural Hospital Organization · JPKawasaki Municipal Hospital · JPKumamoto Medical Center · JPKyoto Prefectural University of Medicine · JPKyoto University Hospital · JPNational Institute of Public Health · JPOkayama University · JPOsaka National Hospital · JPShizuoka Cancer Center · JPShowa University Hospital · JPSt. Marianna University School of Medicine · JPTochigi Cancer Center · JPTohoku University · JPWakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of multiple squamous cell carcinomas (SCC) in the upper aerodigestive tract, which includes the oral cavity, pharynx, larynx, and esophagus, is explained by field cancerization and is associated with alcohol consumption and cigarette smoking. We reviewed the association between alcohol consumption, multiple Lugol-voiding lesions, and field cancerization, mainly based on the Japan Esophageal Cohort study. The Japan Esophageal Cohort study is a prospective cohort study that enrolled patients with esophageal SCC after endoscopic resection. Enrolled patients received surveillance by gastrointestinal endoscopy every 6 months and surveillance by an otolaryngologist every 12 months. The Japan Esophageal Cohort study showed that esophageal SCC and head and neck SCC that developed after endoscopic resection for esophageal SCC were associated with genetic polymorphisms related to alcohol metabolism. They were also associated with Lugol-voiding lesions grade in the background esophageal mucosa, the score of the health risk appraisal model for predicting the risk of esophageal SCC, macrocytosis, and score on alcohol use disorders identification test. The standardized incidence ratio of head and neck SCC in patients with esophageal SCC after endoscopic resection was extremely high compared to the general population. Drinking and smoking cessation is strongly recommended to reduce the risk of metachronous esophageal SCC after treatment of esophageal SCC. Risk factors for field cancerization provide opportunities for early diagnosis and minimally invasive treatment. Lifestyle guidance of alcohol consumption and cigarette smoking for esophageal precancerous conditions, which are endoscopically visualized as multiple Lugol-voiding lesions, may play a pivotal role in decreasing the incidence and mortality of esophageal SCC.

Indexed as

alcoholesophageal cancerfield cancerizationhead and neck cancerJEC study

Identifiers

PMID37409321
PMCPMC10318126
OpenAlexW4383106062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.